Synthesis and biological evaluation of novel N,N′-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors

Add time:08/29/2019    Source:sciencedirect.com

A series of novel N,N′′-diaryl cyanoguanidines were synthesized by reacting diphenyl N-cyanocarbonimidate with sulfanilamide followed by treatment of the obtained cyano-O-phenylisourea with substituted aromatic amines. The newly prepared N,N′′-diaryl cyanoguanidines showed a very interesting inhibition profile against four selected human carbonic anhydrase (CA, EC 4.2.1.1) isoforms, hCA I and hCA II (cytosolic), hCA IV (membrane-bound), and hCA IX (transmembrane). All these compounds showed a potent inhibition against isoform hCA II,with inhibition constants in the low nanomolar range, as well as a high selectivity for hCA II over hCA I, IV and IX. Since hCA II is an important drug target for antiglaucoma agents, these isoform-selective inhibitors may be considered of interest for further medicinal/pharmacologic studies.

We also recommend Trading Suppliers and Manufacturers of N-(3,4-DIMETHYLPHENYL)UREA (cas 114-79-4). Pls Click Website Link as below: cas 114-79-4 suppliers

Prev:Unsymmetrically disubstituted urea derivatives: A potent class of antiglycating agents
Next:Modified carbon paste sensor for the potentiometric determination of Neostigmine bromide (cas 114-80-7) in pharmaceutical formulations, human plasma and urine)